# OnCo record paper-getug-13-fizazi-lancet-oncol-2014 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-getug-13-fizazi-lancet-oncol-2014/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-getug-13-fizazi-lancet-oncol-2014" ;
  schema:name "GETUG 13: personalised chemotherapy based on tumour marker decline in poor-prognosis germ cell tumours"@en ;
  schema:description "In poor-risk testicular cancer, men whose tumour markers fell slowly after the first cycle of BEP did better when switched to an intensified dose-dense regimen, the first trial to individualise chemotherapy by early marker response."@en ;
  schema:url <https://onco.cc/key-papers/paper-getug-13-fizazi-lancet-oncol-2014/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/S1470-2045(14)70490-5>, <https://pubmed.ncbi.nlm.nih.gov/25456363/> ;
  schema:sameAs <https://doi.org/10.1016/S1470-2045(14)70490-5> ;
  schema:datePublished "2014"^^xsd:gYear ;
  schema:author "Fizazi K, Pagliaro L, Laplanche A, et al." ;
  onco:cancers <https://onco.cc/cancers/non-seminoma/> ;
  onco:journals <https://onco.cc/journals/lancet-oncology/> .
